Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre vs Postoperative Dalteparin in Hip Arthroplasty
NCT01714297Phase 4Completed
- Sponsor
- Vestre Viken Hospital Trust
- Start
- Jan 2008
- Primary completion
- Jun 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dalteparin in venous thromboembolism (VTE) (2 arms), sponsored by Vestre Viken Hospital Trust. Primary endpoint: Total blood loss. Started Jan 2008; status: completed.
02
Drugs
dalteparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT01714297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01714297.